Multi-omic analysis of the immune profile of COVID-19 patients showed a significant role of the AP-1/p38MAPK pathway in disease progression. Proteomic analysis of plasma revealed increased levels of IL-6, IL-8, CCL2, CLEC11A, CCL20, CXCL10 and CCL19
Artykuł naukowy opublikowany w Scientific Reports przedstawia wyniki działania krajowego rejestru zaburzeń zapalnych u dzieci (MultiOrgan Inflammatory Syndromes Related Study – MOIS-CoR). W ramach badania
FDA has approved the use of the oral tablet Paxlovid for the treatment of mild-to-moderate COVID-19 in adults and children over 12 years of age
As of December 2021, the development of infrastructure and service offered by the Institute of Bioorganic Chemistry PAS together with the affiliated Poznan Supercomputing and Networking Center via COVID-19 Data Portal Poland (COVID-HUB)
Initial laboratory studies by Pfizer-BioNTech showed that three doses of BNT162b2 vaccine increased the titer of neutralizing antibodies against the new variant SARS-CoV-2 Omicron (B.1.1.529)
A study published in Cell using transcriptomic, radiological and histopathological data showed that SARS-CoV-2 infection induced an influx of profibrotic macrophages (CD163) into the lung.